C‑mannosylation of R‑spondin2 activates Wnt/β‑catenin signaling and migration activity in human tumor cells

  • Authors:
    • Hayato Mizuta
    • Kenta Kuga
    • Takehiro Suzuki
    • Yuki Niwa
    • Naoshi Dohmae
    • Siro Simizu
  • View Affiliations

  • Published online on: April 1, 2019     https://doi.org/10.3892/ijo.2019.4767
  • Pages: 2127-2138
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

R‑spondin2 (Rspo2), one of the four members of the R‑spondin family of proteins, has agonistic activity in the Wnt/β‑catenin signaling pathway, and it is associated with normal development, as well as disease, such as cancer. The present study focused on the C‑mannosylation of Rspo2, which is a novel and unique type of glycosylation that occurs via a C‑C linkage between the tryptophan residue and an α‑mannose. Although Rspo2 has two putative C‑mannosylation sites at residues Trp150 and Trp153, it had not been reported to date whether these sites are C‑mannosylated. Firstly, results from mass spectrometry demonstrated that Rspo2 was C‑mannosylated at the Trp150 and Trp153 residues. Notably, while this C‑mannosylation of Rspo2 resulted in increased extracellular secretion in human fibrosarcoma HT1080 cells, in other human tumor cell lines it inhibited secretion. However, C‑mannosylation had consistent effects on the activation of Wnt/β‑catenin signaling in PANC1 and MDA‑MB‑231 cells, as well as HT1080 cells. Furthermore, overexpression of wild‑type Rspo2 significantly increased the migratory ability of A549 and HT1080 cells, whereas overexpression of a C‑mannosylation‑defective mutant enhanced migration to a lesser degree. These results suggested that C‑mannosylation of Rspo2 may promote cancer progression and that the inhibition of C‑mannosylation may serve as a potential novel therapeutic approach for cancer therapy.
View Figures
View References

Related Articles

Journal Cover

June 2019
Volume 54 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Mizuta, H., Kuga, K., Suzuki, T., Niwa, Y., Dohmae, N., & Simizu, S. (2019). C‑mannosylation of R‑spondin2 activates Wnt/β‑catenin signaling and migration activity in human tumor cells. International Journal of Oncology, 54, 2127-2138. https://doi.org/10.3892/ijo.2019.4767
MLA
Mizuta, H., Kuga, K., Suzuki, T., Niwa, Y., Dohmae, N., Simizu, S."C‑mannosylation of R‑spondin2 activates Wnt/β‑catenin signaling and migration activity in human tumor cells". International Journal of Oncology 54.6 (2019): 2127-2138.
Chicago
Mizuta, H., Kuga, K., Suzuki, T., Niwa, Y., Dohmae, N., Simizu, S."C‑mannosylation of R‑spondin2 activates Wnt/β‑catenin signaling and migration activity in human tumor cells". International Journal of Oncology 54, no. 6 (2019): 2127-2138. https://doi.org/10.3892/ijo.2019.4767